Scholarlink

<p>Patients with recurrent acute flares of pancreatitis—especially those receiving frequent opioid treatment for pain—can develop physiologic dependence to opioids. This can complicate the clinical picture, making it difficult to distinguish between true pancreatitis flares and opioid withdrawal presenting with similar symptoms. We describe two cases of patients admitted recurrently for pancreatitis: a 24-year-old Haitian male with alcohol use disorder, and a 37-year-old Indian female with hypertriglyceridemia. Both developed iatrogenic physiologic opioid dependence after frequent hospitalizations and opioid prescriptions. Both patients stabilized after initiation of buprenorphine, remaining in care and hospitalization-free for over a year. These cases illustrate the importance of identifying and treating the underlying etiology of abdominal pain, judiciously prescribing opioids to treat pancreatitis flares, and having a low threshold for considering iatrogenic physiologic opioid dependence in patients evaluated for recurrent pancreatitis. They also highlight the potential role that buprenorphine can play to mitigate recurrent admissions by providing safer pain control and treatment for physiologic opioid dependence.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Iatrogenic physiologic opioid dependence masquerading as recurrent acute pancreatitis flares: case series

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月12日

查看全文
  • David Dayan-Rosenman,
  • Sara Diletti-Swenson,
  • Nisha Ghayalod,
  • Randi Sokol

摘要

Patients with recurrent acute flares of pancreatitis—especially those receiving frequent opioid treatment for pain—can develop physiologic dependence to opioids. This can complicate the clinical picture, making it difficult to distinguish between true pancreatitis flares and opioid withdrawal presenting with similar symptoms. We describe two cases of patients admitted recurrently for pancreatitis: a 24-year-old Haitian male with alcohol use disorder, and a 37-year-old Indian female with hypertriglyceridemia. Both developed iatrogenic physiologic opioid dependence after frequent hospitalizations and opioid prescriptions. Both patients stabilized after initiation of buprenorphine, remaining in care and hospitalization-free for over a year. These cases illustrate the importance of identifying and treating the underlying etiology of abdominal pain, judiciously prescribing opioids to treat pancreatitis flares, and having a low threshold for considering iatrogenic physiologic opioid dependence in patients evaluated for recurrent pancreatitis. They also highlight the potential role that buprenorphine can play to mitigate recurrent admissions by providing safer pain control and treatment for physiologic opioid dependence.